<ѻý>Checkpoint Inhibitors Whiff in Head and Neck Cancer Trialsѻý> Avelumab, nivolumab-ipilimumab, pembrolizumab miss endpoints in separate studies Sep 23, 2021
<ѻý>Top Science From the World Conference on Lung Cancerѻý> In this podcast, we examine some of the most important studies presented at this year's meeting Sep 23, 2021 podcast
<ѻý>In RA, Little Risk for Recurrent Cancer With Biologic Treatmentѻý> Results important because most trials excluded patients with previous cancer, researchers note Sep 23, 2021
<ѻý>Study Finds More Later-Stage CRC Diagnoses During Pandemicѻý> Japanese registry data reveals increase in stage III colorectal cancer, drops in earlier disease Sep 22, 2021
<ѻý>Survey Says: Support Is Lacking for Cancer's Lingering Effectsѻý> Survivors report dissatisfaction with long-term support Sep 22, 2021
<ѻý>Angiogenesis Inhibitor Slows Extrapancreatic Neuroendocrine Tumorsѻý> Almost 7-month increase in median PFS with addition of axitinib to endocrine therapy Sep 21, 2021
<ѻý>Transarterial Radioembolization Slows Progression of CRC With Liver Metsѻý> Small increase in median PFS when combined with second-line chemotherapy Sep 21, 2021
<ѻý>Androgen-Targeting Combos Show Promise in Prostate Cancerѻý> Trials extend survival in hormone-sensitive disease Sep 21, 2021
<ѻý>Bifunctional Protein Shows Promise in HPV-Related Cancersѻý> Objective responses in 28% of pretreated patients, durable in most cases Sep 20, 2021
<ѻý>Sunitinib Effective in Very Rare Neuroendocrine Tumorѻý> The TKI boosted PFS in patients with malignant pheochromocytoma and paraganglioma Sep 20, 2021
<ѻý>Chemo Plus Keytruda Boosts Overall Survival in Advanced TNBCѻý> KEYNOTE-355 regimen offers "transformative treatment" in PD-L1-positive disease, expert says Sep 20, 2021
<ѻý>ADC Makes a Case for Role in Metastatic HER2-Positive Breast Cancerѻý> Improved progression-free survival in previously treated disease with trastuzumab duocarmazine Sep 20, 2021
<ѻý>Combo Treatment Extends Survival in HR+HER2- Advanced Breast Cancerѻý> MONALEESA-2's "big message": 12.5-month boost in median OS with ribociclib-aromatase inhibitor Sep 19, 2021
<ѻý>Another Possible Option for HER2-Mutated Non-Small Cell Lung Cancerѻý> More than half of patients responded to antibody-drug conjugate targeting HER2 Sep 19, 2021
<ѻý>Adjuvant Pembrolizumab Boosts Recurrence-Free Survival in High-Risk Melanomaѻý> Also, fewer cases of distant recurrences in KEYNOTE-716 trial Sep 19, 2021
<ѻý>Practice-Changing Study in Advanced Cervical Cancerѻý> Improved PFS, OS with pembrolizumab and chemo with or without bevacizumab Sep 18, 2021
<ѻý>Trastuzumab Deruxtecan: New Standard of Care in Pretreated, Advanced Breast Cancer?ѻý> DESTINY-Breast03 turns in "absolutely startling" PFS in HER2-positive metastatic disease Sep 18, 2021
<ѻý>Extended Letrozole Reduced Recurrence Risk in Postmenopausal Breast Cancerѻý> 5 years of the aromatase inhibitor improved disease-free survival vs 2-3 years Sep 17, 2021
<ѻý>As Safety Data on HPV Vaccine Improves, Why Is Parental Hesitancy Going Up?ѻý> Findings suggest "an urgent need" to combat sentiment, restore confidence, researchers say Sep 17, 2021
<ѻý>Rechallenge With PARP Inhibitor Slows Relapsed Ovarian Cancerѻý> Benefits platinum-sensitive disease irrespective of BRCA, homologous repair status, study showed Sep 17, 2021
<ѻý>Some Reassurance on Cancer Risk With RAI Therapy for Hyperthyroidismѻý> No overall risk increase in large meta-analysis, but higher risk seen for thyroid cancer Sep 17, 2021
<ѻý>Longer Hydroxyurea Tied to Improved Sickle-Cell Heart Issuesѻý> Kids on treatment for less than 1 year had a significantly greater prevalence of LV dilation Sep 16, 2021
<ѻý>AI's Help in Colonoscopy Led to Fewer Missed Adenomasѻý> U.S. study explores benefit of newer technology in colon cancer screening, surveillance Sep 15, 2021
<ѻý>More Help on the Way for Lung Cancers With Exon 20 Mutations?ѻý> Early trials of DZD9008 demonstrated responses in over a third of patients Sep 15, 2021
<ѻý>Cancer Vaccine May Boost Anti-EGFR Efficacy in Non-Small Cell Lung Cancerѻý> More than 90% disease control rate, hint of improved PFS in pilot trial Sep 14, 2021
<ѻý>Novel ADC Promising in Certain Non-Squamous Lung Cancersѻý> Response rate topped 50% in patients with EGFR wild-type tumors and high MET expression Sep 14, 2021
<ѻý>Stanley Tucci's Tongue Cancerѻý> The Oscar-nominated actor opens up about his private battle Sep 13, 2021
<ѻý>More Data in Support of Surgery for Malignant Pleural Mesotheliomaѻý> Six-month improvement in overall survival with surgery plus chemotherapy versus chemo alone Sep 13, 2021
<ѻý>Meta-Analysis Confirms Benefits of Low-Dose CT Screening for Lung Cancerѻý> LDCT associated with a 16% relative reduction in mortality versus no screening Sep 13, 2021
<ѻý>Best Way to Recover Urinary Continence After Prostatectomy?ѻý> Nerve-sparing prostatectomy, not rehab or duloxetine, most important factor Sep 13, 2021
<ѻý>Which Prostate Biopsy Is Best: Transrectal or Transperineal?ѻý> Advocates for one may face uphill battle, debate at AUA meeting suggests Sep 13, 2021
<ѻý>Immuno-Oncology Combo Active in Recurrent EGFR/ALK Positive NSCLCѻý> Responses in 42% of EGFR group, limited activity in ALK-rearranged lung cancer Sep 12, 2021
<ѻý>Triplet Therapy Proves Safe in Resectable Malignant Pleural Mesotheliomaѻý> Atezolizumab add-on offers promising outcomes in phase I trial Sep 12, 2021
<ѻý>Plant-Based Diet Tied to Better Urological Health in Menѻý> "Eat more plants for your prostate and your erections Sep 12, 2021
<ѻý>Durable Response with Immunotherapy Combos in NSCLC with Brain Metastasesѻý> Analysis of CheckMate 9LA data and phase II study from Spain offer hope in advanced disease Sep 12, 2021
<ѻý>Darolutamide Tied to Symptom Control in Non-Metastatic Prostate Cancerѻý> Analysis of ARAMIS trial results also shows QoL benefits with androgen receptor inhibitor Sep 12, 2021
<ѻý>9/11 Responders Face Higher Risk of Multiple Cancersѻý> Longer follow-up sheds light on the long-term consequences of exposure to disaster site Sep 10, 2021
<ѻý>Durable Responses With IL-15 Superagonist in Early Bladder Cancerѻý> Addition of N-803 led to better responses in BCG-unresponsive disease Sep 10, 2021
<ѻý>Dual Immunotherapy Boosts Survival in Metastatic NSCLCѻý> Benefit with durvalumab-tremelimumab may vary by PD-L1 expression, histology Sep 10, 2021
<ѻý>Cancer Patients, COVID-19, and Long-Term Effectsѻý> Preventing COVID sequelae can minimize disruption of cancer care, European study finds Sep 09, 2021